Aveanna Healthcare Holdings Inc

Healthcare US AVAH

4.96USD
-0.12(2.36%)

Last update at 2025-06-13T16:46:00Z

Day Range

4.905.08
LowHigh

52 Week Range

2.006.19
LowHigh

Fundamentals

  • Previous Close 5.08
  • Market Cap1012.50M
  • Volume160032
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA138.38M
  • Revenue TTM1983.47M
  • Revenue Per Share TTM10.31
  • Gross Profit TTM 553.23M
  • Diluted EPS TTM-0.35

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -663.81400M -113.57600M -51.73400M -75.03000M -49.65900M
Minority interest - - - - -
Net income -662.03400M -117.04400M -57.05000M -76.51600M -47.14600M
Selling general administrative 483.95M 427.77M 354.77M 341.00M 321.84M
Selling and marketing expenses - - - - -
Gross profit 553.23M 542.40M 454.51M 419.25M 394.32M
Reconciled depreciation 38.82M 35.39M 30.22M 27.01M 11.94M
Ebit 26.30M 95.97M 81.95M 38.95M 41.46M
Ebitda 65.12M 131.36M 112.17M 71.80M 53.40M
Depreciation and amortization 38.82M 35.39M 30.22M 32.84M 11.94M
Non operating income net other 86.18M -8.53500M - - -
Operating income 26.30M 95.97M 81.95M 38.95M 39.03M
Other operating expenses 1754.48M 1584.19M 1413.30M 1322.45M 1199.06M
Interest expense 99.94M 68.93M 82.98M 92.30M 75.54M
Tax provision -1.78000M 3.47M 5.32M 1.49M -2.51300M
Interest income 0.68M 0.25M 0.34M 0.21M 0.59M
Net interest income -107.04100M -68.67700M -82.63800M -92.08900M -74.94800M
Extraordinary items - - - - -
Non recurring 675.45M 130.53M - - -
Other items - - - - -
Income tax expense -1.78000M 3.47M 5.32M 1.49M -2.51300M
Total revenue 1787.64M 1678.62M 1495.11M 1384.07M 1253.67M
Total operating expenses 520.06M 447.98M 372.71M 357.64M 339.71M
Cost of revenue 1234.42M 1136.21M 1040.59M 964.81M 859.35M
Total other income expense net -690.11900M -209.54300M -133.68500M -113.98400M -29.32100M
Discontinued operations - - - - -
Net income from continuing ops -662.03400M -117.04400M -57.05000M -76.51600M -47.14600M
Net income applicable to common shares -662.03400M -117.04400M -57.05000M -76.51600M -47.14600M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 1637.16M 1711.76M 2334.37M 1844.02M 1578.43M
Intangible assets 94.01M 95.86M 102.85M 73.57M 54.30M
Earning assets - - - - -
Other current assets 25.14M 9.81M 9.20M 11.34M 8.56M
Total liab 1764.60M 1715.93M 1696.42M 1576.85M 1307.49M
Total stockholder equity -129.57000M -4.17500M 637.95M 267.17M 270.94M
Deferred long term liab - 3.84M 3.05M 3.80M 0.80M
Other current liab 141.59M 249.58M 129.00M 149.63M 3.42M
Common stock 1.91M 1.89M 1.85M 1.42M 1.37M
Capital stock 1.91M 1.89M 1.85M 1.42M 1.37M
Retained earnings -1371.23400M -1236.71000M -574.67600M -457.63200M -400.58200M
Other liab - 62.54M 64.35M 82.57M 54.42M
Good will 1054.55M 1159.69M 1835.58M 1316.38M 1226.06M
Other assets - 27.36M 33.36M 34.55M 31.26M
Cash 43.94M 19.22M 30.49M 137.34M 3.33M
Cash and equivalents - - - - -
Total current liabilities 354.76M 326.50M 344.83M 260.41M 168.54M
Current deferred revenue - 3.84M 135.96M 29.44M 77.85M
Net debt 1455.25M 1336.13M 1267.95M 1091.06M 1076.31M
Short term debt 183.04M 28.45M 27.25M 24.67M 20.86M
Short long term debt 13.15M 15.38M 13.71M 2.87M 2.03M
Short long term debt total 1499.19M 1355.35M 1298.44M 1228.40M 1079.64M
Other stockholder equity 1237.62M 1230.65M 1210.78M 723.38M 670.16M
Property plant equipment - 22.75M 31.37M 78.87M 80.47M
Total current assets 314.89M 269.75M 279.21M 340.64M 186.34M
Long term investments - - - - -
Net tangible assets - -1259.72600M -1300.48000M -1122.78800M -1009.41900M
Short term investments - - - - -
Net receivables 245.81M 225.63M 225.29M 180.88M 164.30M
Long term debt 1276.34M 1281.08M 1226.52M 1163.49M 31.50M
Inventory - 15.09M 14.23M 11.08M 10.16M
Accounts payable 30.13M 44.62M 52.62M 56.67M 66.42M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 2.13M - - -31.29300M -20.62200M
Additional paid in capital - - - - -
Common stock total equity - 1.89M 1.85M 1.42M 1.37M
Preferred stock total equity - - - - -
Retained earnings total equity - -1236.71000M -574.67600M - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 4.67M 105.26M 33.36M 7.63M 5.19M
Deferred long term asset charges - - - - -
Non current assets total 1322.28M 1442.01M 2055.16M 1503.37M 1392.09M
Capital lease obligations 54.70M 58.89M 58.22M 52.13M 51.99M
Long term debt total - 1281.08M 1226.52M - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -11.72500M 1.03M -193.54400M -17.82400M -229.54700M
Change to liabilities 3.50M -23.61200M -6.81100M 19.29M 21.51M
Total cashflows from investing activities -25.29100M -681.83100M -193.54400M -17.82400M -229.54700M
Net borrowings 68.10M 1416.85M 166.13M 68.94M 149.73M
Total cash from financing activities 62.42M 586.33M 210.94M 21.86M 204.15M
Change to operating activities -35.07100M -50.82200M 54.78M -9.56900M 21.20M
Net income -662.03400M -117.04400M -57.05000M -76.51600M -47.14600M
Change in cash -11.27300M -106.85500M 134.02M -4.67400M -3.79800M
Begin period cash flow 30.49M 137.34M 3.33M 8.00M 11.80M
End period cash flow 19.22M 30.49M 137.34M 3.33M 8.00M
Total cash from operating activities -48.40200M -11.35000M 116.62M -8.71400M 21.60M
Issuance of capital stock 0.00000M 477.69M 50.00M 0.00000M 54.42M
Depreciation 38.82M 35.39M 30.22M 27.01M 11.94M
Other cashflows from investing activities -13.56600M -681.83100M -681.83100M -681.83100M -681.83100M
Dividends paid - - - - -
Change to inventory - -27.05800M 3.48M -13.19500M 15.40M
Change to account receivables -3.22700M -8.80800M 8.56M 3.34M -7.95500M
Sale purchase of stock 4.01M 475.51M - - -
Other cashflows from financing activities 116.97M 1421.58M 218.91M 612.93M 171.49M
Change to netincome 580.23M 85.14M 79.37M 21.00M 16.67M
Capital expenditures 12.01M 15.95M 15.24M 16.64M 19.58M
Change receivables -3.22700M -8.80800M - - -
Cash flows other operating 4.03M 1.81M - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes -11.27300M -106.85500M - - -
Change in working capital -42.22300M -71.32800M 56.54M 13.06M 34.76M
Stock based compensation 15.89M 14.43M 3.27M 1.95M 2.12M
Other non cash items 601.26M 125.89M 90.06M 26.70M 23.56M
Free cash flow -60.41500M -27.30000M 101.38M -25.35100M 2.02M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AVAH
Aveanna Healthcare Holdings Inc
-0.12 2.36% 4.96 - 60.61 0.51 1.17 1.15 17.51
HCA
HCA Holdings Inc
2.09 0.56% 373.76 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR
-0.01 0.08% 12.80 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc
- -% 5.10 62.50 35.97 0.30 2.32 0.16 3.90
JDHIF
JD Health International Inc
- -% 3.23 57.75 32.68 0.29 2.11 0.16 3.90

Reports Covered

Stock Research & News

Profile

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Aveanna Healthcare Holdings Inc

400 Interstate North Parkway SE, Atlanta, GA, United States, 30339

Key Executives

Name Title Year Born
Mr. Rodney D. Windley Exec. Chairman 1948
Mr. Tony Strange CEO & Director 1963
Mr. David Afshar CPA Chief Financial Officer 1972
Mr. Jeffrey Shaner Chief Operating Officer 1973
Mr. Shannon L. Drake Gen. Counsel & Chief Legal Officer 1976
Mr. Ed Reisz Chief Admin. Officer 1959
Mr. Patrick A. Cunningham Chief Compliance Officer 1956
Ms. Beth Rubio Chief Clinical Officer 1957
Ms. Korey Hinz Pres of Medical Solutions NA
Mr. Robert Radics Pres of Home Health & Hospice NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.